In this context, the ATM and ATR kinases, as key mediators of the DNA damage response, have become part of an attractive therapeutic concept in cancer therapy in connection with the use of selective ATM and ATR inhibitors [58,59] that have the potential to be very effective against tumors with a high level of replication stress [60]. The gene discussed is ATM; the disease is cancer.